Rolland Carlson
Immunexpress announced today that it has appointed Rolland Carlson as CEO. Carlson previously served as president and CEO of WaferGen Biosystems. Before WaferGen, Carlson was president and CEO of Asurgen, where he established company operations and developed 17 clinical products and services. Prior to Asuragen, Carlson held senior positions at Abbott Laboratories over a 20-year period.